Diagnoses of attention deficit hyperactivity disorder (ADHD) are rising rapidly in the UK. More children and teenagers than ever are being referred for assessment and support, and families are often facing long waits and limited options once a diagnosis is made. Schools, health services and parents are all under growing pressure to find treatments that genuinely help children manage their difficulties with attention, impulsivity and activity levels.
By
NIHR Maudsley BRC at 23 Jan 2026
New research from the Institute of Psychiatry, Psychology & Neuroscience at King’s College London, in partnership with YoungMinds, has examined the image-posting habits on social media of young people who self-harm. The study found that young people temporarily withdraw from posting images on the day they self-harm.
By
NIHR Maudsley BRC at 21 Jan 2026
A large multicentre clinical trial led by King’s College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.
By
NIHR Maudsley BRC at 16 Jan 2026
In 2025, NIHR Maudsley BRC delivered research with real-world impact from evaluating new treatments for depression and migraine to developing innovative approaches to monitoring opioid overdose and diagnosing eating disorders.
By
NIHR Maudsley BRC at 19 Dec 2025
The Child Mental Health & Neurodevelopmental Disorders theme at the NIHR Maudsley BRC has completed its leadership team with the appointment of senior colleagues from the Insitute of Psychiatry, Psychology & Neuroscience and South London and Maudsley NHS Foundation Trust
By
NIHR Maudsley BRC at 14 Oct 2025
